Pharma & Biotech
Assembly Biosciences Gains Favor as Clinical Data Prompts Analyst Upgrades
Growing optimism surrounds Assembly Biosciences following the release of compelling interim data from its Phase 1b study targeting herpes simplex...
PDS Biotechnology Shares Gain Momentum from Regulatory and Patent Developments
PDS Biotechnology Corporation has recently activated multiple catalysts that could provide fresh impetus for its stock. The company secured a...
Akero Therapeutics Acquisition Finalized, Shares Delisted from Nasdaq
The publicly traded chapter for Akero Therapeutics has officially closed. The company’s shares, previously listed under the ticker symbol "AKRO"...
Sellas Life Sciences Shares Surge on Encouraging Clinical Trial Data
Shares of Sellas Life Sciences are posting significant gains in today's trading session. This upward momentum follows the release of...
Zimmer Biomet Shares Face Selling Pressure Amid Divergent Investor Moves
Shares of medical device manufacturer Zimmer Biomet are experiencing notable downward pressure in today's trading session. This movement follows disclosures...
Healwell AI Shares Struggle to Gain Traction Despite Strong Revenue Growth
Investors continue to apply selling pressure on Healwell AI, with its shares failing to stabilize even after the company reported...
BioNTech’s Oncology Ambitions Gain Momentum with Promising Trial Data
For investors in BioNTech, the company's long-stated pivot beyond its COVID-19 vaccine foundation has awaited concrete validation. This week, the...
Ginkgo Bioworks Shares Surge on Major Government Contract Win
Shares of Ginkgo Bioworks Holdings Registered (A) posted significant gains in Friday's trading session. The catalyst was the announcement of...
Navigating Oncology Rivals: AbbVie’s Strategic Position Under Scrutiny
Monday's trading spotlight falls on AbbVie as the market weighs competing clinical data releases. The pharmaceutical giant finds itself at...
Arrowhead Pharmaceuticals Enters Commercial Era with Landmark Drug Approval
The biotechnology firm Arrowhead Pharmaceuticals has reached a defining corporate milestone, transitioning from a research-focused entity to a commercial-stage company....
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings
